全文获取类型
收费全文 | 1363篇 |
免费 | 90篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 108篇 |
妇产科学 | 57篇 |
基础医学 | 139篇 |
口腔科学 | 27篇 |
临床医学 | 176篇 |
内科学 | 253篇 |
皮肤病学 | 21篇 |
神经病学 | 31篇 |
特种医学 | 311篇 |
外科学 | 110篇 |
综合类 | 17篇 |
预防医学 | 30篇 |
眼科学 | 7篇 |
药学 | 30篇 |
肿瘤学 | 145篇 |
出版年
2023年 | 6篇 |
2022年 | 15篇 |
2021年 | 21篇 |
2019年 | 9篇 |
2018年 | 24篇 |
2017年 | 11篇 |
2016年 | 11篇 |
2015年 | 22篇 |
2014年 | 34篇 |
2013年 | 35篇 |
2012年 | 34篇 |
2011年 | 36篇 |
2010年 | 35篇 |
2009年 | 34篇 |
2008年 | 22篇 |
2007年 | 45篇 |
2006年 | 20篇 |
2005年 | 36篇 |
2004年 | 23篇 |
2003年 | 16篇 |
2002年 | 20篇 |
2001年 | 17篇 |
2000年 | 18篇 |
1999年 | 23篇 |
1998年 | 96篇 |
1997年 | 71篇 |
1996年 | 80篇 |
1995年 | 52篇 |
1994年 | 63篇 |
1993年 | 69篇 |
1992年 | 15篇 |
1991年 | 15篇 |
1990年 | 17篇 |
1989年 | 46篇 |
1988年 | 29篇 |
1987年 | 45篇 |
1986年 | 25篇 |
1985年 | 29篇 |
1984年 | 30篇 |
1983年 | 23篇 |
1982年 | 27篇 |
1981年 | 25篇 |
1980年 | 29篇 |
1979年 | 8篇 |
1978年 | 18篇 |
1977年 | 19篇 |
1976年 | 22篇 |
1975年 | 14篇 |
1974年 | 4篇 |
1940年 | 6篇 |
排序方式: 共有1464条查询结果,搜索用时 15 毫秒
81.
82.
薄层扫描法测定黄芪生脉颗粒中黄芪甲甙含量 总被引:5,自引:0,他引:5
目的:制订黄芪生脉颗粒中黄芪甲甙含量测定方法。方法:双波长薄层扫描法,经乙酰洗涤、正丁醇提取和D101大乳吸附树脂柱层析法制备样品,以氯仿-甲醇-水(13:7:2)下层液为展开剂,检测波长为510nm,参比波长为700nm。结果:加标回收率平均为98.7%(RSD=2.0%,n=6),标准曲线r=0.9966,重复性RSD=1.4%(n=5),精密度RSD=2.0%(n=6)。结论:方法稳定、可靠 相似文献
83.
84.
Ketai LH; Williamson MR; Telepak RJ; Levy H; Koster FT; Nolte KB; Allen SE 《Radiology》1994,191(3):665
85.
The testicular scintigraphic findings of nine patients with surgically and pathologically proved torsion of the testis of over 24 hours duration are reviewed. In the delayed blood-pool images each showed the classical avascular twisted testicle with a variable peripheral rim of hyperemia. In the dynamic blood-flow phase, eight revealed a perceptible increase of vascular perfusion in the scrotal region on the affected side, in addition to the testicular radionuclide angiogram peculiarities previously described for missed testicular torsion. This pattern of perfusion was seen only in torsion of over one day duration. A low salvage probability is expected in these cases. 相似文献
86.
W Oh DK Stevenson JE Tyson BH Morris CE Ahlfors G Jesse Bender RJ Wong R Perritt BR Vohr KP Van Meurs HJ Vreman A Das DL Phelps T Michael O’Shea RD Higgins 《Acta paediatrica (Oslo, Norway : 1992)》2010,99(5):673-678
Objectives: To assess the influence of clinical status on the association between total plasma bilirubin and unbound bilirubin on death or adverse neurodevelopmental outcomes at 18–22 months corrected age in extremely low birth weight infants. Method: Total plasma bilirubin and unbound bilirubin were measured in 1101 extremely low birth weight infants at 5 ± 1 days of age. Clinical criteria were used to classify infants as clinically stable or unstable. Survivors were examined at 18–22 months corrected age by certified examiners. Outcome variables were death or neurodevelopmental impairment, death or cerebral palsy, death or hearing loss, and death prior to follow‐up. For all outcomes, the interaction between bilirubin variables and clinical status was assessed in logistic regression analyses adjusted for multiple risk factors. Results: Regardless of clinical status, an increasing level of unbound bilirubin was associated with higher rates of death or neurodevelopmental impairment, death or cerebral palsy, death or hearing loss and death before follow‐up. Total plasma bilirubin values were directly associated with death or neurodevelopmental impairment, death or cerebral palsy, death or hearing loss, and death before follow‐up in unstable infants, but not in stable infants. An inverse association between total plasma bilirubin and death or cerebral palsy was found in stable infants. Conclusions: In extremely low birth weight infants, clinical status at 5 days of age affects the association between total plasma bilirubin and death or adverse neurodevelopmental outcomes at 18–22 months of corrected age. An increasing level of UB is associated a higher risk of death or adverse neurodevelopmental outcomes regardless of clinical status. Increasing levels of total plasma bilirubin are directly associated with increasing risk of death or adverse neurodevelopmental outcomes in unstable, but not in stable infants. 相似文献
87.
88.
89.
Prof. Dr. W. Janni J. Jückstock A. Schneeweiss J. Huober H. Sommer E. Stickeler P. A. Fasching B. Rack B. Gerber K. Friese 《Der Gyn?kologe》2008,41(8):575-584
Systemic therapy has led to significant mortality reductions, particularly in breast cancer. Treatment of side effects resulting from such therapy is therefore also of major importance in controlled and thorough systemic treatment. Speedy diagnosis and initiation of the indicated therapy is decisive in countering infection associated with chemotherapy. In the case of clinically relevant febrile neutropenia, complete diagnostics should be done and treatment started with leukopoiesis stimulation factors and empiric antibiotics administration. Many different substance classes are used for antiemetic treatment, the most potent of which are 5-HT3 and neurokinin-1 receptor antagonists. Corticosteroids also show good antiemetic results, and their combination with 5-HT3 und NK-1 antagonists is the most effective. Other gastrointestinal symptoms such as diarrhea, obstipation, and mucositis can be successfully treated. This article summarizes supportive treatment options for adverse events during cytostatic treatment and gives hands-on recommendations for clinical practice. 相似文献
90.
We characterized neutrophil autoantigens using an immunoblotting technique with antibodies obtained from patients with autoimmune neutropenia. These results were correlated with serologic characterization of the antibodies, using indirect immunofluorescence and leukoagglutination. Of the 17 sera immunoblotted, 16 showed discrete bands in the molecular weight range of 30 to 112. Three patients with Felty's syndrome reacted with an antigenic target of 80 to 84 Kd molecular mass, a finding not seen in any of the other patients studied. By serologic testing, none of the autoimmune sera showed serologic specificity for any known neutrophil-specific alloantigen. Using an anti-NA-1 serum, we identified antigenic targets at 40, 50, and 101 Kd in both NA-1-positive and NA-1-negative neutrophils. Ten of 17 autoimmune sera showed reactivity in this corresponding range. These studies demonstrate that immunoblotting may be used to identify antigenic targets in autoimmune neutropenia and may suggest a specificity of these antibodies not definable by serologic techniques. Correlation of immunoblot reactivity with disease states associated with immune neutropenia may be useful in the study of the pathogenesis of the different forms of autoimmune neutropenia. 相似文献